OLIGOPROGRESSIVE METASTATIC DISEASE
Clinical trials for OLIGOPROGRESSIVE METASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new OLIGOPROGRESSIVE METASTATIC DISEASE trials appear
Sign up with your email to follow new studies for OLIGOPROGRESSIVE METASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Three-Pronged attack: new combo aims to stop spreading kidney cancer
Disease control Recruiting nowThis study is testing a three-part treatment for people whose advanced kidney cancer has started to spread again in a few spots. It combines a drug injected into a tumor to activate the immune system, very precise radiation to those spreading spots, and continued immunotherapy. T…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Zapping spreading spots: can radiation extend control of advanced melanoma?
Disease control Recruiting nowThis study is testing whether adding focused, high-dose radiation to a small number of spots where melanoma is spreading can help patients stay on their current drug treatments longer. It involves adults with advanced melanoma whose cancer is mostly controlled by immunotherapy or…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Zapping cancer spots could delay need for harsher drugs
Disease control Recruiting nowThis study is testing if using precise, high-dose radiation on a few spreading cancer spots can control advanced prostate cancer better than the current standard, which is to switch medications. It will compare keeping patients on their current drugs while adding radiation agains…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Precision radiation vs. standard care: a blind test for halting Cancer's advance
Disease control Recruiting nowThis study aims to see if a more precise, high-dose form of radiation (SABR) is better than standard palliative radiation at controlling cancer when it has spread to only a few new spots. About 194 adults with solid cancers that have progressed in up to five locations will be ran…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Zapping spots of spreading cancer could buy more time
Disease control Recruiting nowThis trial is for people with advanced cancer that has spread but is only growing in a few spots. It compares two approaches: using targeted local treatments like radiation or surgery on those few growing spots versus switching to a new drug therapy. The goal is to see if treatin…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Targeted radiation zaps tumors, could keep breast cancer drugs working longer
Disease control Recruiting nowThis study is for women with a specific type of advanced breast cancer (ER+/HER2-) whose current hormone-based medications are starting to fail at 1-3 spots in the body. Researchers want to see if using very precise, high-dose radiation (called SBRT) on just those few growing tum…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC